BioRestorative Therapies (BRTX) to Release Quarterly Earnings on Thursday

BioRestorative Therapies (NASDAQ:BRTX) is expected to be announcing its earnings results on Thursday, March 27th. Analysts expect the company to announce earnings of ($0.34) per share and revenue of $0.48 million for the quarter.

BioRestorative Therapies Stock Performance

NASDAQ BRTX opened at $1.71 on Friday. The business has a 50 day simple moving average of $1.97 and a 200 day simple moving average of $1.71. BioRestorative Therapies has a 52-week low of $1.03 and a 52-week high of $2.55. The stock has a market cap of $11.83 million, a price-to-earnings ratio of -1.12 and a beta of 64.37.

About BioRestorative Therapies

BioRestorative Therapies, Inc, a life sciences company, focuses on the development of regenerative medicine products and therapies using cell and tissue protocols primarily involving adult stem cells. The company's two core developmental programs relate to the treatment of disc/spine disease and metabolic disorders.